logo
All you need to know about: prostate cancer

All you need to know about: prostate cancer

The Hindu19-05-2025

Former United States president Joe Biden was diagnosed with prostate cancer last week, with his office announcing that it was an 'aggressive' form of the disease, as cancer cells had spread to the bone. His office however, also said that the cancer appeared to be hormone-sensitive which 'allows for effective management' and that the president and his family are reviewing treatment options with his physicians.' Many political leaders, including current U.S. President Donal Trump sent Mr. Biden wishes for his recovery.
What is prostate cancer?
Prostate cancer is a cancer that develops in the prostate gland, which is part of the male reproductive system. The prostate gland is about the size of a walnut but tends to grows with age. It is located just below the bladder, in front of the rectum. The main job of the prostate gland is to produce a fluid that becomes part of the semen.
Prostate cancer is a common cancer: according to 'The Lancet Commission on prostate cancer: planning for the surge in cases', 2024, prostate cancer is the most common cancer by incidence in men in 112 countries (as of 2020), and accounts for one in every 14 cancers diagnosed globally, and 15% of all male cancers. Among men, the disease ranks second only to lung cancer in terms of cancer mortality. In the United States, it is second only to skin cancer among men, while in India, it is third-most common cancer among men as of 2022.
What are the risk factors of prostate cancer?
Risk factors for prostate cancer include: age -- as men grow older, their risk of getting prostate cancer increases; family history -- men who have had a close family member with prostate cancer have an increased chance of getting it; obesity -- studies have linked being overweight to having a greater chance of getting prostate cancer. Other risk factors include ethnicity as African American men are at greater risk.
What are the signs and symptoms of prostate cancer?
In the early stages, prostate cancer may not always cause symptoms. When symptoms do occur, they may include: a frequent need to urinate, trouble passing urine or a weak flow or pain and burning while urinating, blood in the urine (making it look pink or red), blood in the semen, pain in the lower back, hips or thighs and painful ejaculation.
Severity of symptoms may depend on where the cancer is located and how advanced it is. Changes in urinary functions could also be symptoms of a common condition, an enlarged prostate -- it is important to consult a doctor for the right diagnosis.
What are the stages of prostate cancer?
Healthcare providers may use a scale known as the Gleason score to determine how serious the cancer is. Under the Gleason score, the more abnormal cells you have, the higher your score. These scores range from 2 to 10. A score of below of 5 is not considered cancer. Scores from 6 to 10 are considered cancer -- with 6 being a slow-growing cancer and 10 being a fast-growing cancer.
The cancer is also staged. In the early stages (stages 1 and 2), the cancer is localised and has not spread beyond the prostate. In the locally advanced stage or stage 3, it has spread outside the prostate but only to nearby tissue and structures. In the advanced or metastasised stage or stage 4, it has spread to other parts, possibly lymph nodes, bones, liver, lungs or other organs.
What is the treatment for prostate cancer?
Treatment depends on several factors including age and overall health condition, the stage and grade of the cancer and its spread. Early-stage cancers can have a good outcome with treatment.
One treatment option for small and slow-growing cancers may be active surveillance, where the patients gets screened and tested regularly to monitor the cancer grow. If tests show that the cancer is growing, then other treatment options may be considered.
Other treatment options include surgery, radiation therapy and systemic therapies.
Surgery, known as prostatectomy, is the removal of the prostate gland. It may be used when the cancer is just in the prostate gland and has not spread. Radiation therapy uses high-energy beams to kills the cancer. It may be offered in combination with other treatments as well.
Systemic therapies can include hormone therapy, which involves using medication to stop the hormone testosterone from boosting cancer cell growth. Chemotherapy uses medication to destroy cancer cancer. In immunotherapy, medicines are used to strengthen the immune system to fight off cancer cells. Targeted therapy involves finding the specific mutations that cause healthy cells to become cancerous and prevent this. Other, newer forms of therapy, some of which are still considered experimental, such as focal therapy involve destroying the tumour inside the prostate without having to remove it.
What are the projections for prostate cancer?
The Lancet Commission projects that the number of new cases of prostate cancer annually, will rise from 1·4 million in 2020 to 2·9 million by 2040. Changing age structures and improving life expectancy are predicted to drive big increases in the disease, it says.
The Commission also states that late diagnosis of prostate cancer is widespread worldwide but especially in low and middle income countries (LMICs), where late diagnosis is the norm. 'The only way to mitigate the harm caused by rising case numbers is to urgently set up systems for earlier diagnosis in LMICs. Trials of screening are urgently needed in LMICs to better inform ways to improve early diagnosis,' it says.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Study reveals biological process of how air pollution increases premature birth risk
Study reveals biological process of how air pollution increases premature birth risk

The Hindu

timea day ago

  • The Hindu

Study reveals biological process of how air pollution increases premature birth risk

Researchers from Emory University in the US analysed blood samples from 330 African American pregnant women in the Atlanta metropolitan area. Women living in downtown and midtown neighbourhoods, where several highways intersect, had a higher level of exposure to pollution over a year, compared to those living on the outskirts of the city, the team said. Vehicular emissions are a major contributor to PM2.5 pollution. Two substances -- 'cortexolone' and 'lysoPE(20:3)' -- involved in the relationship between short-term exposure to air pollution and an elevated risk of early births, were identified. Cortexolone is a glucocorticoid crucial to regulating metabolism, inflammation, and the immune response, while lysoPE(20:3) is a lipid present in cells and important for cell function. Study highlights The findings, published in the Environmental Science and Technology journal, highlighted disruptions in how proteins are digested and absorbed -- vital to foetal development and immune function -- which potentially serve as a link between exposure to air pollution and premature deliveries. The changes were associated with an increased risk of various negative birth outcomes, including premature birth, the researchers said. "The link between air pollution and premature birth has been well established, but for the first time we were able to look at the detailed pathway and specific fine particles to identify how they are reflected in the increased risk of adverse birth outcomes," lead author Donghai Liang, associate professor of environmental health at Emory University, said. "This is important because if we can figure out the 'why' and 'how' then we can know better how to address it," Liang added. Of the 330 women participants, 66 (20 per cent) delivered preterm babies -- before 37 weeks of pregnancy -- and 54 (16.4 per cent) delivered early term babies -- occurring between 37 and 38 weeks and 6 days of pregnancy -- both of which are significantly higher than the prevalence in the general US population, the researchers said. The authors wrote, "We identified significant indirect effects of cortexolone and lysoPE(20:3) in mediating the relationship between PM2.5 and early births." "Perturbations in protein digestion and absorption and aromatic amino acid metabolism may potentially mediate the associations between PM2.5 and early births." Liang said that while even lower levels of air pollution are harmful, people cannot simply be asked to move away from highly polluted areas. "So, from a clinical intervention standpoint, it's critical to gain a better understanding of these pathways and molecules affected by pollution. In the future, we may be able to target some of these molecules to develop effective strategies or clinical interventions that could help reduce these adverse health effects," the lead author added.

Study reveals biological process of how air pollution increases premature birth risk
Study reveals biological process of how air pollution increases premature birth risk

Time of India

time2 days ago

  • Time of India

Study reveals biological process of how air pollution increases premature birth risk

New Delhi: A study has uncovered the biological process by which pregnant women exposed to PM2.5 air pollution could be at a higher risk of premature deliveries. Researchers from Emory University in the US analysed blood samples from 330 African American pregnant women in the Atlanta metropolitan area. Women living in downtown and midtown neighbourhoods, where several highways intersect, had a higher level of exposure to pollution over a year, compared to those living on the outskirts of the city, the team said. Vehicular emissions are a major contributor to PM2.5 pollution. Two substances -- 'cortexolone' and 'lysoPE(20:3)' -- involved in the relationship between short-term exposure to air pollution and an elevated risk of early births, were identified. Cortexolone is a glucocorticoid crucial to regulating metabolism, inflammation, and the immune response, while lysoPE(20:3) is a lipid present in cells and important for cell function. The findings, published in the Environmental Science and Technology journal, highlighted disruptions in how proteins are digested and absorbed -- vital to foetal development and immune function -- which potentially serve as a link between exposure to air pollution and premature deliveries. The changes were associated with an increased risk of various negative birth outcomes, including premature birth, the researchers said. "The link between air pollution and premature birth has been well established, but for the first time we were able to look at the detailed pathway and specific fine particles to identify how they are reflected in the increased risk of adverse birth outcomes ," lead author Donghai Liang, associate professor of environmental health at Emory University, said. "This is important because if we can figure out the 'why' and 'how' then we can know better how to address it," Liang added. Of the 330 women participants, 66 (20 per cent) delivered preterm babies -- before 37 weeks of pregnancy -- and 54 (16.4 per cent) delivered early term babies -- occurring between 37 and 38 weeks and 6 days of pregnancy -- both of which are significantly higher than the prevalence in the general US population, the researchers said. The authors wrote, "We identified significant indirect effects of cortexolone and lysoPE(20:3 ) in mediating the relationship between PM2.5 and early births." "Perturbations in protein digestion and absorption and aromatic amino acid metabolism may potentially mediate the associations between PM2.5 and early births." Liang said that while even lower levels of air pollution are harmful, people cannot simply be asked to move away from highly polluted areas. "So, from a clinical intervention standpoint, it's critical to gain a better understanding of these pathways and molecules affected by pollution. In the future, we may be able to target some of these molecules to develop effective strategies or clinical interventions that could help reduce these adverse health effects," the lead author added. PTI

Joe Biden's Daughter Slams 'Untrue' Claims On Ex-US President's Health: 'Damn Disrespectful'
Joe Biden's Daughter Slams 'Untrue' Claims On Ex-US President's Health: 'Damn Disrespectful'

News18

time3 days ago

  • News18

Joe Biden's Daughter Slams 'Untrue' Claims On Ex-US President's Health: 'Damn Disrespectful'

Last Updated: Ashely Biden captioned the post with a message: 'Too grateful to be angry about all the bulls**t." Ashley Biden, daughter of former US President Joe Biden, hit back at recent reports about her father's mental and physical health, calling the claims 'DAMN disrespectful and untrue." In an Instagram post, Ashley Biden posted a photo of herself with her parents, Joe and Jill Biden, at the beach. She captioned the post with a message: 'Too grateful to be angry about all the bulls**t," adding, 'This family's only coverup is a beach coverup." Ashley Biden's comments come amid speculation about the former president's health, particularly in the wake of books such as Original Sin. Rejecting the claims, Ashley Biden wrote, 'He aged, YES! As we all do! And the stress of the presidency accelerates. But he was always MORE than capable of doing the job. And a damn good one." Ashley Biden took aim at what she called 'recent noise from fake news" accusing some in the media of pushing false narratives for profit. She wrote, 'The noise is so DAMN disrespectful and untrue… created by those committed to perpetuating and profiting from some real BS. Get lost with your fake news and anonymous sources." Ashley also thanked the public for the outpouring of support following her father's recent prostate cancer diagnosis. Her comments follow a similar rebuke from Joe Biden's granddaughter Naomi Biden, who criticized Original Sin in a post on X (formerly Twitter), calling the book 'political fairy smut" written by 'irresponsible self-promoting journalists." First Published: June 03, 2025, 23:16 IST

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store